Skip to main content

International Psoriasis Council

International Psoriasis Council
subscribe
4   What's New
Search
subscribe
Search

Advancing Knowledge. Improving Care.

Andrew

Blauvelt

,

MD, MBA

Consultant
University of Maryland School of Medicine
Baltimore
,
Maryland
,
United States
Councilor Since: October 1, 2011
IPC Board Member
Request an Update
Dr. Andrew Blauvelt is a Consultant at Blauvelt Consulting, LLC. He received his undergraduate degree in electrical engineering from Purdue University, his medical degree from Michigan State University, and a Master of Business Administration (MBA) in health care at Oregon Health & Science University (OHSU). Dr. Blauvelt trained in dermatology at the University of Miami and in cellular immunology under the direction of Steve Katz at the National Institutes of Health (NIH). Earlier in his career, he held senior staff positions at the NIH (Senior Investigator), OHSU (Professor), and the Portland Veterans’ Affairs Medical Center (Chief), as well as serving as Owner and President of Oregon Medical Research Center (OMRC) from 2013 to 2022. Within psoriasis immunology research, Dr. Blauvelt’s laboratory published critical papers on the role of IL-23/Th17 biology in this disease. In the clinic, he founded and ran OHSU’s Center of Excellence for Psoriasis and Psoriatic Arthritis, one of the first centers in the country to provide multidisciplinary care for patients with psoriasis. In recent years, while at OMRC, he was the international lead/senior investigator on numerous important clinical trials in psoriasis, including PSTELLAR, FEATURE, CLEAR, IXORA-R, VOYAGE 1, ECLIPSE, IMMhance, BE ABLE 1, BE ABLE 2, BE READY, BE RADIANT, OASIS-1, POETYK PSO-1, and KNOCKOUT. Dr. Blauvelt has published over 450 papers and spoken worldwide on all aspects of psoriasis. Dr. Blauvelt is also an elected member of the American Society for Clinical Investigation, the International Psoriasis Council (IPC), and the International Eczema Council (IEC), and is currently the Chair of the Medical Board for the National Psoriasis Foundation (NPF), an organization he has worked with for over 25 years in various capacities.
Last Updated:
09/09/2026

Areas of Interest

Immunology, Clinical Trials, Biologics

IPC Committees / Groups

Board Member, Digital Health Working Group, Disease Severity Working Group, Finance Committee

Languages Spoken

English

Involvement with Other Organization(s)

Dr. Blauvelt is the current chair of the National Psoriasis Foundation (NPF) Medical Board.
Recent publications

Featured

Blog

IPC Symposium at the 2026 Society for Investigative Dermatology (SID) Annual Meeting: Disease Interception, Treatment…

Read summaries from the IPC symposium at the 2026 Society for Investigative Dermatology (SID) Annual Meeting covering…

Read More

PDF

A Report from the 2026 American Academy of Dermatology (AAD) Annual Meeting.

What were the key takeaways from the 2026 AAD Annual Meeting? IPC shares updates on diagnostic challenges, psoriasis…

View Report

Blog

Highlights from the 2026 American Academy of Dermatology (AAD) Annual Meeting: Diagnostic Complexity, Therapeutic…

What were the key takeaways from the 2026 AAD Annual Meeting? IPC shares updates on diagnostic challenges, psoriasis…

Read More

Video

Tuberculosis Screening for IL 17i and IL 23i.

In this Take Ten with IPC video, Dr. Andrew Blauvelt discusses a recent joint publication from the International…

Watch Video

Video

Knocking Out Psoriasis.

In this Take Ten with IPC video, Dr. Andrew Blauvelt discusses the KNOCKOUT study, a randomized phase 2 clinical trial…

Watch Video

Blog

2025 IPC Think Tank Congress Report: Psoriasis, Metabolic Health, and GLP-1 Therapies.

The 2025 IPC Think Tank Congress Report highlights psoriasis as a systemic immunometabolic disease, linking obesity,…

Read More

PDF

Joint Position Statement from the National Psoriasis Foundation Medical Board and the International Psoriasis Council…

The International Psoriasis Council (IPC) and the National Psoriasis Foundation (NPC) have released a joint position…

View Report

PDF

Establishing Consensus on Defining Failure of Topical Therapy in Psoriasis: Recommendations from the International…

Early and effective treatment in psoriasis mitigates cumulative chronic disease burden and may prevent psoriatic…

View Report

Blog

Focus on Psoriasis: Highlights from the 2025 ESDR Annual Meeting.

The 2025 ESDR Congress in Antwerp brought together over 1,000 dermatology researchers. This report summarizes the…

Read More

Blog

Focus on Psoriasis: Highlights from the 2025 EADV Congress.

At the 2025 EADV Annual Meeting in Paris, experts shared new insights into psoriasis diagnosis, symptoms, and…

Read More

Blog

Advancing Biosimilars and Optimizing Psoriasis Treatment: Highlights from the 2025 ICD Symposium.

Experts from across five continents discuss regional biosimilar uptake and practical strategies for optimizing…

Read More

Blog

Focus on Psoriasis: Highlights from the 2025 Society for Investigative Dermatology (SID) Annual Meeting.

IPC’s 2025 SID Congress Report highlights the most impactful psoriasis sessions, covering novel cell-biology…

Read More

Blog

Highlights from the 2025 American Academy of Dermatology (AAD) Annual Meeting: Psoriasis Comorbidities, New Treatments,…

The 2025 AAD Annual Meeting featured important updates on psoriasis therapies, comorbidities, and late-breaking…

Read More

PDF

A Report from the 2025 American Academy of Dermatology (AAD) Annual Meeting.

The 2025 AAD Annual Meeting featured important updates on psoriasis therapies, comorbidities, and late-breaking…

View Report

Blog

Focus on Psoriasis: A Report from the Psoriasis: From Gene to Clinic 10th International Congress.

The Psoriasis: From Gene to Clinic Congress Report highlights breakthroughs in genetics, clinical care, and treatment…

Read More

Blog

Focus on Psoriasis: A Report from the 2024 American Academy of Dermatology (AAD) Annual Meeting.

The 2024 American Academy of Dermatology (AAD) Annual Meeting was held Thursday, March 7 – Tuesday, March 12, 2024,…

Read More

Video

Hot Psoriasis Topics: Single Cell RNA Sequencing.

Dr. Andrew Blauvelt provides insights into the recent advancements in single-cell and RNA sequencing technologies.

Watch Video

Blog

Getting to Know IPC's Board Member Andrew Blauvelt: What Inspired Me to Specialize in Psoriasis.

Join Dr. Andrew Blauvelt, a dedicated dermatologist, researcher, and a vital member of the International Psoriasis…

Read More

Event

Symposium: The Comprehensive Care of Psoriasis.

AMERICAN ACADEMY OF DERMATOLOGY ANNUAL MEETING (AAD) | SAN DIEGO, CALIFORNIA Thursday, March 7 14:00 - 18:00…

March 7, 2024
Learn More or Register

Link

Psoriasis Location Affects Quality of Life.

The International Psoriasis Council and the National Psoriasis Foundation publish findings on psoriasis disease…

View More

What's New

Psoriasis: An Expert Global Perspective Is Now Available for Pre-Order

IPC Board Member and Treasurer Joel Gelfand, MD, MSCE, is the editor of a new textbook, Psoriasis: An Expert Global Perspective, now available for preorder from Elsevier. He worked with associate editors IPC President Bruce Strober, MD, PhD; IPC Vice President/President-Elect Claudia de la Cruz, MD; and IPC Chief Medical Officer Peter van de Kerkhof, MD, PhD. Nearly 50 authors from 20 countries contributed 30 chapters covering psoriasis from its earliest descriptions through genetics, immunology, and current therapies, with clinical images of psoriasis across diverse skin tones. All royalties support IPC.

PRE-ORDER YOUR COPY

Thursday, September 10, 2026

New Video Resource: Early Diagnosis and Treatment of Psoriatic Arthritis (PsA)

In this video, IPC Councilor Rodrigo Garcia Salinas, MD, a rheumatologist from Argentina, explains how to recognize psoriatic arthritis early, including why joint pain, how long a patient has had psoriasis, and family history can matter more than skin severity alone. He also reviews how imaging helps catch early disease and how to choose treatment based on each patient’s joint, spine, and skin involvement.

WATCH NOW

Friday, September 25, 2026

Take Ten Video: Bridging Psoriasis and Metabolic Comorbidities

IPC President Bruce Strober reviews the link between psoriasis and metabolic disease, drawing on findings from IPC’s recent paper in the Journal of the American Academy of Dermatology (JAAD). He translates this growing body of evidence into five concrete priorities from the 2025 IPC Think Tank for improving cardiometabolic screening and care.

WATCH NOW

Wednesday, September 9, 2026